Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

Proposal would let patients get Wegovy, Ozempic, related drugs for obesity, which is not a covered condition now.

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden ...

The Biden-Harris administration proposed a new rule on Tuesday that would expand coverage of the anti-obesity medications ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...

One of the main reasons Ozempic and other GLP-1 agonist medications are so effective is because they target your brain, not ...

The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...